[A case of Tsutsugamushi disease with multiple organ involvement].

G. Koike,H. Ikematsu,T. Otsuka,K. Kushimoto,K. Fujimoto,T. Kusaba,Y. Niho,N. Tachibana

DOI: https://doi.org/10.11150/KANSENSHOGAKUZASSHI1970.62.748

1988-08-01

Abstract:

What problem does this paper attempt to address?

Epstein-Barr virus-associated leiomyosarcoma of the larynx in an adult patient with human immunodeficiency virus infection: Case report and review of the literature

Jian-Di Jin,Zhe Chen,Zai-Zai Cao,Shui-Hong Zhou,Xiu-Ming Zhang,Hong-Tian Yao

DOI: https://doi.org/10.1002/hed.27184

2022-01-01

Abstract:We investigated the clinical features, treatment, and prognosis of laryngeal leiomyosarcoma (LLMS) and Epstein-Barr virus-associated (EBV-associated) LMS. We report a case of EBV-associated LLMS in an adult patient with HIV infection. We also conducted a review of the English-language literature on LLMS and EBV-associated leiomyosarcoma. To the best of our knowledge, 62 cases of LLMS and EBV-associated leiomyosarcoma have been reported to date. Of patients with LLS, 18.9% had distant metastases and 17.0% had local recurrence. The overall 5-year survival rate was 64.0%. Distant metastases affected the survival of patients with LLMS (p = 0.04). EBV-positive patients had a low survival rate (p = 0.01). Among patients with EBV-associated LMS, 8.2% had distant metastases and recurrence and the overall 5-year survival rate was 50.0%. EBV-associated LLMS is rare. The EBV infection might be a poor prognostic factor of LLMS.
Epstein–Barr Virus‐associated Leiomyosarcoma of the Larynx in an Adult Patient with Human Immunodeficiency Virus Infection: Case Report and Review of the Literature

Jian-di Jin,Zhe Chen,Zai-Zai Cao,Shuihong Zhou,Xiuming Zhang,H. Yao

DOI: https://doi.org/10.1002/hed.27184

2022-01-01

Head and Neck

Abstract:We investigated the clinical features, treatment, and prognosis of laryngeal leiomyosarcoma (LLMS) and Epstein–Barr virus‐associated (EBV‐associated) LMS. We report a case of EBV‐associated LLMS in an adult patient with HIV infection. We also conducted a review of the English‐language literature on LLMS and EBV‐associated leiomyosarcoma. To the best of our knowledge, 62 cases of LLMS and EBV‐associated leiomyosarcoma have been reported to date. Of patients with LLS, 18.9% had distant metastases and 17.0% had local recurrence. The overall 5‐year survival rate was 64.0%. Distant metastases affected the survival of patients with LLMS (p = 0.04). EBV‐positive patients had a low survival rate (p = 0.01). Among patients with EBV‐associated LMS, 8.2% had distant metastases and recurrence and the overall 5‐year survival rate was 50.0%. EBV‐associated LLMS is rare. The EBV infection might be a poor prognostic factor of LLMS.
Closures and dichotomies for quantified constraints

T. Feder,Phokion G. Kolaitis

Abstract:Quantified constraint satisfaction is the generalization of con- straint satisfaction that allows for both universal and existential quantifiers over constrained variables, instead of just existential quantifiers. We study quantified constraint satisfaction problems CSP(Q,S), where Q denotes a pattern of quantifier alternation ending in exists or the set of all possible alternations of quantifiers, and S is a set of relations constraining the com- binations of values that the variables may take. These problems belong to the corresponding level of the polynomial hierarchy or in PSPACE, depend- ing on whether Q is a fixed pattern of quantifier alternation or the set of all possible alternations of quantifiers. We also introduce and study the quan- tified constraint satisfaction problems CSP 0 (Q,S) in which the universally quantified variables are restricted to range over given subsets of the domain. We first show that CSP(Q,S) and CSP 0 (Q,S) are polynomial-time equiv- alent to the problem of evaluating certain syntactically restricted monadic second-order formulas on finite structures. After this, we establish three broad sufficient conditions for polynomial-time solvability of CSP 0 (Q,S) that are based on closure functions; these results generalize and extend earlier results by other researchers about polynomial-time solvability of CSP(Q,S). Our study culminates with a dichotomy theorem for the com- plexity of list CSP 0 (Q,S), that is, CSP 0 (Q,S) where the relations of S include every subset of the domain of S. Specifically, list CSP 0 (Q,S) is ei- ther solvable in polynomial-time or complete for the corresponding level of the polynomial hierarchy, if Q is a fixed pattern of quantifier alternation (or PSPACE-complete if Q is the set of all possible alternations of quantifiers). The proofs are based on a more general unique sink property formulation.
Epstein-Barr Virus-Associated Lymphoepithelioma-Like Gastric Carcinoma Located on Gastric High Body: Two Case Reports.

Yanfeng Bai,Qiqi Gao,Guoping Ren,Bo Wang,Hua Xiang

DOI: https://doi.org/10.4103/0377-4929.138775

2014-01-01

Indian Journal of Pathology and Microbiology

Abstract:Lymphoepithelioma-like gastric carcinoma (LELGC) is a rare neoplasm of the stomach with an incidence of 1-4% of all gastric cancers. It is characterized by the presence of a lymphoid stroma with cells arranged primarily in micro alveolar, thin trabecular, and primitive tubular patterns or isolated cells. It is one of the histological patterns observed in patients with Epstein - Barr virus (EBV)-associated gastric carcinoma (EBVaGC). In situ hybridization was usually used to confirm the presence of EBV. There are two types of EBVaGC, LELGC, and ordinary type. Approximately, 15-25% of EBVaGC exhibit the LELGC pattern. Here, we described two cases of LELGC and the related literatures were reviewed as well. The two cases were submucosal mass from a 59- or 63-year-old man. We found LELGC has special clinicopathologic features and protein expression profile. This should promote us to make a true diagnosis.
Pulmonary lymphoepithelioma-like carcinoma

Lin Zhou,Lu-ting Li,Xin-yi Liu,Shao-jin Zhang,Yanming He

DOI: https://doi.org/10.1097/MD.0000000000024453

IF: 1.6

2021-02-05

Medicine

Abstract:Abstract Rationale: Pulmonary lymphoepithelioma-like carcinoma (PLELC) is a rare type of primary malignant lung tumor characterized by Epstein-Barr virus infection, with, to the authors’ knowledge, a total of only 500 reported cases during the past 30 years worldwide. Histologically, PLELC is similar to undifferentiated nasopharyngeal carcinoma and poorly differentiated squamous cell carcinoma. However, although PLELC accounts for <1% of all lung cancers, it has a better prognosis and is usually detected in non-smokers and individuals of Asian ancestry. Patient concerns: The patient presented with chest distress of no apparent cause, dizziness, headaches, and a feeling of disequilibrium without remission, as well as a pulmonary nodule incidentally detected on contrast-enhanced computed tomography (CT). Diagnosis: PLELC was confirmed histopathologically rather than on preoperative CT; nevertheless, CT findings still contributed to the diagnosis. Interventions: The patient underwent thoracoscopic wedge resection of the affected lung. Outcomes: The patient recovered after the lung nodule was completely removed, and was discharged. No evidence of recurrence or metastasis was found at the latest follow-up appointment 2 months after the operation. Lessons: PLELC is a rare bronchogenic carcinoma associated with lymphatic tissue with a favorable prognosis in most cases. With nonspecific clinical symptoms, specific radiological findings may facilitate an early diagnosis in some cases, followed by timely surgical intervention.

Medicine
P35.22 WITHDRAWN

Lintao Wang,Xiaonan Liu,Xue Yu,Ziqi Zhao,Yong Zhang,Yi Bai,Shujun Zhang,Youlong Xu,Pan Zhao,Hong Bao,Xinqiang Wang,Ruifeng Liu,Ruochen Xu,Jingjing Xiang,Hanliang Jiang,Yan Jiang,Xuesong Wu,Yi Shao,Liang Ji,Qiong Wu,Zulin Zhang,Shuai Lü,Shenglin Ma

DOI: https://doi.org/10.1016/j.jtho.2021.01.723

IF: 20.121

2021-01-01

Journal of Thoracic Oncology

Abstract:pulmonary lymphoepithelioma-like carcinoma (PLELC), a rare subtype of non-small cell lung cancer (NSCLC).However, the understanding of the treatment for EBV-infected NSCLC was still elusive.Immunotherapy that targets PD-1/PD-L1 has been utilized as a novel clinical treatment in recent years.Here, we focus on the genomic landscapes of lung cancers with EBV-infection and its correlation with PD-L1.Methods: Patients with both PD-L1 expression detection and genomic information were screened in HapLab database.HaploX 605-gene panel sequencing, covering 1.31 MB genome, was performed to analyze the genomic data of patients.PD-L1 expression was detected by immunochemistry.Bioinformatic analysis of genomic mutations and the correlation with the expression of PD-L1 were studied.Results: We analyzed the genomic profiles of 23 EBV-infected NSCLC patients.11 cases of lung squamous-cell carcinoma (LUSC), 4 cases of lung adenocarcinoma (LUAD), 5 cases of lung pulmonary lymphoepithelioma-like carcinoma (PLELC), and 3 unidentified cases were included in this study.Collectively, 93 genome mutations of 67 genes were detected in 23 EBV-infection cases.Top 3 frequently mutated genes were TP53 (27%), CSMD3 (18%) and KMT2D (18%).The EBV-infected patients exhibited a low level of tumor mutation burden (TMB).The median TMB was 1.53 Muts/MB (ranging from 0 to 14.5 Muts/MB).Only 3 of 23 patients (13.0%) harbored the canonical driver mutations in NSCLC.Interestingly, 10/23 patients (43.5%) showed high expression of PD-L1, while 13/23 patients (56.5%) showed low expression.We also assessed the expression of PD-L1 in lung cancers with no EBV-infection (867 cases).Only 118/867 (13.6%) patients without EBV-infection presented high PD-L1 expression, while 749/867 (86.4%) presented low PD-L1 expression.Conclusion: EBV-infection can occur in different kinds of NSCLC, including LUSC, LUAD, and PLELC.TMB and driver mutations of EBV-infected NSCLC were not frequently observed as normal lung cancers, implying a different mechanism leading to EBVinfected lung cancers.Interestingly, EBV-infected NSCLC tended to have a high correlation with the expression of PD-L1.This may give a hint on the application of checkpoint blockade immunotherapy on EBV-infected NSCLC.
Surgical Treatment of Epstein-Barr Virus–associated Lymphoepithelioma-Like Carcinoma Occurring in Both the Posterior Mediastinum and Liver

Xiao-Hui Qian,Dong-Kai Zhou,Wei-Lin Wang

DOI: https://doi.org/10.1097/md.0000000000023610

IF: 1.6

2020-01-01

Medicine

Abstract:Abstract Rationale: Lymphoepithelioma-like carcinoma (LELC) is a rare malignant tumor that can occur in many areas of the body. The pathogenesis of LELC remains unknown, but Epstein-Barr virus (EBV) has been shown to be strongly correlated with LELC at several anatomic sites, including the lungs and thymus. To the best of our knowledge, EBV-associated LELC has never been reported in both the posterior mediastinum and liver. Herein, we report the case of a 41-year-old female diagnosed with LELC in both the posterior mediastinum and liver and discuss whether it is beneficial to perform surgery on advanced LELC when resectable metastases are found. Patient concerns: The patient was a 41-year-old woman who had been suffering from intermittent pain in the upper right quadrant for 3 months without obvious cause and was admitted to our hospital with occasional nausea without vomiting. Diagnosis: Her cancer antigen 125 and cytokeratin 19 fragment levels were elevated, whereas alpha-fetoprotein and alanine aminotransferase were normal. Computed tomography (CT) and magnetic resonance imaging revealed a mass in the S6 segment of the liver. Whole-body positron emission tomography/computed tomography (PET/CT) revealed a 3.2-cm mass in the posterior mediastinum and a 6.7-cm mass on the right side of the liver. We made a diagnosis of LELC based on the histological and immunohistochemical findings of specimens obtained by operation. However, it was difficult to determine the primary origin of the tumor. Interventions: The patient underwent mediastinal tumor resection, hepatectomy, and diaphragmatic repair. Thereafter, she was administered paclitaxel and cisplatin as adjuvant chemotherapy. Outcomes: The postoperative course was uneventful, and the patient was discharged 10 days later. Although she was administered paclitaxel and cisplatin as adjuvant chemotherapy, we noted recurrence during the 4-month follow-up examination. Then, the patient passed away 5 months after surgery. Lessons: We present the first case of LELC found in both the posterior mediastinum and liver and describe the functionality of PET/CT for finding occult carcinomas and identifying their primary tumor origin. Additional studies are urgently needed to discover whether it is beneficial to perform surgery on advanced LELC when resectable metastases are revealed by PET/CT.
Lymphocytic hypophysitis presenting early in pregnancy

D. Kidd,P. Wilson,B. Unwin,N. Dorward

DOI: https://doi.org/10.1007/s00415-003-0209-y

2003-11-01

Journal of Neurology

Abstract:
[A Rare Case of Non-small Cell Lung Carcinoma Squamous Phenotype with Epstein-Barr Virus Positivity with Prolonged Response to both Chemotherapy and Radiotherapy].

CarolinaNavarro RODRIGUEZ,MuhammadShahid IQBAL,Max ROBINSON,Graham BURNS,Alastair GREYSTOKE,Carolina Navarro Rodriguez,Muhammad Shahid Iqbal,Max Robinson,Graham Burns,Alastair Greystoke

DOI: https://doi.org/10.3779/j.issn.1009-3419.2021.101.15

2021-07-21

Chinese Journal of Lung Cancer

Abstract:We present a rare challenging case of metastatic non-small cell lung cancer with Epstein-Barr virus positivity that was also diagnosed with pulmonary tuberculosis at the same time. Palliative chemotherapy gemcitabine and carboplatin was started after two weeks of anti-tuberculosis treatment with the hopes that this period would be sufficient to keep acid fast bacilli non-viable to minimise risk of tuberculosis re-activation due to chemotherapy induced immunosuppression. She completed four cycles of chemotherapy and six months of anti-tuberculosis treatment with good results and minimal side effects. Two years later, there was disease recurrence in cervical and mediastinal lymph nodes which was treated with local treatment i.e. surgery and palliative radiotherapy. It has been two years since last radiotherapy and overall more than five years since diagnosis with no active disease at present. Given the complexity and rarity of this case, significant multidisciplinary team involvement, including oncologists and radiation oncologists, pulmonologists with special interest in tuberculosis and pathologists was necessary throughout.

English Else
Isolation of viruses from mosquitoes collected at Lumbo, Mozambique. I. Lumbo virus, a new virus isolated from Aedes (Skusea) pembaensis Theobald.

R. Kokernot,B. Mcintosh,C. Worth,DE MORAIST,M. Weinbren

DOI: https://doi.org/10.4269/AJTMH.1962.11.678

1962-09-01

American Journal of Tropical Medicine and Hygiene

Abstract:Summary Twelve strains of a hitherto unknown virus have been isolated from Aedes (Skusea) pembaensis collected in 1959 and 1960 at Lumbo in northeastern Mozambique. The name proposed for the agent is Lumbo. Lumbo virus is filterable and withstands lyophilization but is sensitive to sodium desoxycholate. It is pathogenic for adult mice and hamsters by the intracerebral but not the intraperitoneal inoculation route. Vervet monkey, yellow baboon, bushbaby and guinea pig develop an immune response to the virus without showing signs of illness. Viremia was detected on the 3rd and 4th postinoculation days in a vervet monkey. Of 128 human sera collected at Lumbo and Ndumu, northern Natal, in the tropical corridor in southeastern Africa, 16 contained neutralizing antibodies; all of 175 human sera collected in Angola and the Caprivi Strip were negative.
A Clinical Analysis and Literature Review of Six Cases with Primary Pulmonary Lymphoepithelioma-Like Carcinoma

Lingyan Ye,Dinghai Luo,Haiyan Li,Haihong Zheng,Susu He,Ling Lin,Yicheng Fang,Junhui Ye,Chengshui Chen

DOI: https://doi.org/10.1155/2022/1086697

IF: 2.809

2022-04-29

Computational and Mathematical Methods in Medicine

Abstract:Object. To investigate the clinicopathological features, imaging findings, treatment, and prognosis of primary pulmonary lymphoepitheliomatoid-like carcinoma. Methods. The clinical data of six patients with primary pulmonary lymphoepithelioma-like carcinoma treated in Zhejiang Taizhou Hospital of Taizhou Enze Medical Center (Group) from May 2014 to December 2018 were summarized and analyzed. Combined with the relevant literature, the primary pulmonary lymphoepithelioma-like carcinoma was analyzed retrospectively. Results. The main manifestations of six patients were respiratory symptoms, and cough was the most common. The imaging features of six patients were mainly round-like high-density mass shadow or nodule shadow. All patients were diagnosed by pathology. Microscopically, the cancer cells were nested, with large nuclei and vacuoles and abundant lymphocyte infiltration in the tumor stroma. The positive rates of EBER, p63, CK5/6, and Ki-67 were high, and TTF-1 was negative. Five patients received surgical treatment. One patient developed brain metastasis 12 months after operation and received craniocerebral radiotherapy. The other patients did not receive radiotherapy and chemotherapy, and one patient did not receive treatment. After follow-up, four patients survived so far, the longest survival time was 82 months, one patient lost follow-up, and one patient died of lung metastasis 24 months after operation. Conclusion. Primary pulmonary lymphoepitheliomatoid-like carcinoma is a rare lung malignant tumor, whose pathogenesis is related to Epstein-Barr virus infection. The clinical manifestations are nonspecific, but with unique pathological characteristics. Surgical resection is the proper treatment for early-stage patients, and comprehensive treatment with surgery as the main treatment is suitable for late-stage patients. The prognosis is good.

mathematical & computational biology
Primary lymphoepithelioma-like carcinoma of the lung: An unusual cancer and clinical outcomes of 14 patients

Lan Lin,Tingyan Lin,Bangwei Zeng

DOI: https://doi.org/10.3892/ol.2017.6510

Abstract:Advanced lung cancer is considered to exhibit a poor prognosis; however, the pulmonary lymphoepithelioma-like carcinoma (LELC), a rare subtype of non-small cell lung cancer (NSCLC), exhibits an improved prognosis, compared with non-LELC. The present study aimed at investigating the clinical manifestation, imaging characteristics, pathology, tumor markers, treatment and prognosis of primary LELC of the lung. A total of 14 patients with pulmonary LELC were confirmed by surgery and pathology. Clinical data of those patients were retrospectively reviewed including age, sex, smoking history, symptoms, computed tomography (CT) results, Epstein-Barr virus-encoded RNA (EBER) status, treatment and outcomes. In the present study, there were 7 males and 7 females who ranged in age between 22 and 64 years (mean, 51.21±11.37 years) and who all were from eastern China. The tumor-node-metastasis stage ranged between stages I and IV, with 71.43% of the patients at advanced stage (stages III and IV). The results of the present study identified 100% positive expression of EBER. Tumors located centrally were of significantly increased size, compared with peripheral tumors (P<0.05), and lymphadenopathy was more common in patients with advanced stage (P<0.05). The majority of patients were treated with surgery, platinum-based chemotherapy or radiotherapy. At time of writing, 12 patients were alive and the longest survival time was 60 months. Pulmonary LELC typically affected young patients and was not associated with smoking history; however, pulmonary LELC was associated with Epstein-Barr virus infection in the Asian population. The majority of patients were in early or locally advanced stages and exhibit an improved prognosis compared with other types of NSCLC. Pulmonary LELC was sensitive to chemotherapy and surgery, with postoperative chemotherapy-based multimodality treatment recommended.
PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival

Wenfeng Fang,Shaodong Hong,Nan Chen,Xiaobo He,Jianhua Zhan,Tao Qin,Ting Zhou,Zhihuang Hu,Yuxiang Ma,Yuanyuan Zhao,Ying Tian,Yunpeng Yang,Cong Xue,Yanna Tang,Yan Huang,Hongyun Zhao,Li Zhang

DOI: https://doi.org/10.18632/oncotarget.5028

2015-08-19

Oncotarget

Abstract:BACKGROUD: Programmed cell death-ligand 1 (PD-L1) and driver mutations are commonly seen in non-small-cell lung cancer (NSCLC). However, the prevelance of PD-L1 over-expression and its prognostic value in Epstein-Barr virus (EBV) associated pulmonary lymphoepithelioma-like carcinoma (LELC) remains poorly understood.METHODS: A total of 214 NSCLC patients and 113 surgically treated pulmonary LELC patients were included. Paraffin-embedded tumor sections were stained with PD-L1 antibody. Correlations between PD-L1 expression and clinicopathological features as well as survival outcomes were analyzed.RESULTS: The frequency of PD-L1 over-expression in NSCLC was 51.4%. No significant association was observed between common driver mutations and PD-L1 over-expression. Remakably, the positive rate of PD-L1 in pulmonary LELC was 74.3%. High PD-L1 expression was associated with impaired disease-free survival (DFS) compared with low PD-L1 expression (p = 0.008). Multivariate analysis shows that PD-L1 expression level, N stage and M stage were independent prognostic factors for DFS. N stage and M stage but not PD-L1 expression level were significantly associated with overall survival (OS).CONCLUSIONS: PD-L1 over-expression was not related to common driver mutations in NSCLC. Pulmonary LELC have remarkably high incidence of PD-L1 expression. PD-L1 was a negative prognostic factor for DFS in surgically resected pulmonary LELC. These findings may provide a rationale for immunotarget therapy in this virus-associated lung cancer.
Clinical observation of pulmonary lymphoepithelioma-like carcinoma

Zhou Sha,Yajun Wei,Tinghua Gao,Yuanling Luo,Jiaqun Chen,Ting Li,Liyang Hu,Xiaoli Niu,Zhong Lin,Weize Lv,Xiaofeng Pei,Zhou Sha,Yajun Wei,Tinghua Gao,Yuanling Luo,Jiaqun Chen,Ting Li,Liyang Hu,Xiaoli Niu,Zhong Lin,Weize Lv,Xiaofeng Pei

DOI: https://doi.org/10.21037/jtd-21-1369

2021-10-01

Journal of Thoracic Disease

Abstract:BACKGROUND: Lymphoepithelioma-like carcinoma (LELC) of the lung is a rare type of non-small cell lung cancer (NSCLC), and researches of it are still not enough.METHODS: In this study, we retrospectively analyzed 36 patients with LELC diagnosed in the Fifth Affiliated Hospital of Sun Yat-sen University and Zhaoqing First People's Hospital from January 2014 to June 2021, to investigate the clinical manifestations, tumor markers, treatment, and prognosis of LELC. Clinical data including age, gender, smoking history, family history of cancers, Epstein-Barr virus (EBV) encoding RNA (EBER) status, gene mutations, programmed death-ligand 1 (PD-L1) expression, treatment, and prognosis.RESULTS: There was a total of 36 participants in this study, 16 males and 20 females, the median age was 57 years (37-76 years). A total of 22 cases (61.1%) were advanced (stage III and IV), and EBER was 94.4% positive. Most patients were treated with surgery, platinum chemotherapy, or radiotherapy. At the time of 31 June 2021, 33 participants had survived, and the longest survival time was 72 months. Lung LELC was more common in old participants (≥59 years) and was not associated with smoking history. Expression of PD-L1 was positive in the majority (27 cases, 75%) and participants with positive PD-L1 expression tended to have longer progression-free survival (PFS) and overall survival (OS) time than those with negative PD-L1 expression.CONCLUSIONS: Pulmonary LELC usually occurs in non-smoking patients and is associated with EBV infection. Common treatments for tumors include multimodal therapy. The expression of PD-1 may be related to the prognosis of LELC, but more studies are needed to support further optimization of the treatment of LELC.

respiratory system
Neoadjuvant Therapy Before Resection of Primary Pulmonary Lymphoepithelial Carcinoma

Erik Wu,Joseph Reznicek,Anjana V. Yeldandi,Jyoti D. Patel,David D. Odell

DOI: https://doi.org/10.1016/j.cllc.2024.01.007

IF: 4.84

2024-01-31

Clinical Lung Cancer

Abstract:Primary lymphoepithelial carcinoma (LEC) of the lung is an extremely rare subset of non-small cell lung cancer (NSCLC) with less than 500 documented cases since its identification in 1987. A vast majority of these cases occur in east or southeast Asia and have been associated with Epstein-Barr Virus (EBV). While localized disease has been managed via surgical resection or resection followed by adjuvant chemotherapy, there is no current consensus on definitive treatment strategy. A 64-year-old patient who had immigrated from Vietnam 35 years ago presented with intermittent cough and was found to have a left lower lobe mass on chest computerized tomography. Positron emission tomography revealed this mass to be hypermetabolic with potential mediastinal and perihilar lymph node activity, suggestive of cT4N2M0 or stage IIIB disease. Immunohistochemistry from transbronchial needle biopsy performed under endobronchial ultrasound demonstrated poorly differentiated EBV-associated LEC. In addition, 90% of the tumor cells were found to have positive programmed death-ligand 1 (PDL1) expression. The patient was started on neoadjuvant chemo-immunotherapy with cisplatin/docetaxel and nivolumab and completed 3 cycles before reassessment. The patient's primary pulmonary LEC mass demonstrated 40% reduction after 3 cycles of neoadjuvant therapy. The patient underwent left lower lobectomy with lymph node sampling. Pathology showed significant down staging to ypT1N0 disease and patient is doing well post-operatively. This represents the first documented case of neoadjuvant therapy being used in primary pulmonary LEC. Here, neoadjuvant chemotherapy plus checkpoint immunotherapy was shown to be a viable alternative to previously attempted strategies for pulmonary LEC, broadening options for effective management. Furthermore, additional discussion details the state of current research into pulmonary LEC.

oncology
Lymphoepithelioma-like carcinoma of the lung: a rare case report and review of the literature

Ali Fırıncıoğluları,Berna Akıncı Özyürek,Yurdanurr Erdoğan,Funda İncekara,Emre Yılmaz,Hatice Esra Özaydın

DOI: https://doi.org/10.5578/tt.69322

Tuberk Toraks

Abstract:Lymphoepithelioma-like carcinoma (LELC), is a rare type of cancer and typically occurs in pharyngeal and foregut-derivative organs, Including the salivary glands, thymus, stomach and liver (1). Pulmonary LELC typically affects the young and non-smoking population, and is associated with Ebstein-Barr virus (EBV) infection (1,2). We present an rare case with a pulmonary mass on CT scan of the thorax, which was subsequently proved as a LELC of the lung and a brief review of the relevant literature. The patient is a 51-year old man, presented with shorthness of breath and cough for 1 months. Chest x-ray was normal (Figure 1). Chest CT scan showed a 30-25 mm heterogeneously enhanced mass lesion with well defined margin, In the left lower lobe of the lung (Figure 2). Bronchoscopy showed no endobronchial lesion. After the PET-CT, the patient was staged as cT2aN1M0 (Stage 2B) (Figure 3). He received video-assisted thoracoscopic surgery of left lower lobe of lung and mediastinal lymph nodes dissection (Figure 4,5). His Ebv-Dna is Positive in blood tests. The pathology, immunohistochemical staining,and in situ hybridization results confirmed LELC of lung (Figure 6). Using in situ hybridization with exhibition of abundant EBV-encoded small nuclear RNA, in the majority of tumor cells is done. He received 4 cycles of induction chemotherapy with cysplatine and vinoralbine. The patient was discharged from hospital with close follow-up. No recurrence has been detected so far. Primary pulmonary LELC is a rare malignant tumor which accounts for only 0.9% of all primary lung cancer (1,2). Previous studies have demonstrated that pulmonary LELC is strongly associated with EBV infection (1,2). The majority of pulmonary LELC patients receive complete resection, as well as chemotherapy and radiotherapy based on their clinical stage (1,2). Comparing to other non-small cell cancer (NSCLC), pulmonary LELC is more sensitive to chemotherapy and radiotherapy (1,2). LELC of lung may be mistaken histopathologically for metastatic nasopharyngeal carcinoma or lymphoma. Its association with latent EBV infection have major implications for diagnosis and treatment. We present this case, because, its an unusual case with a pulmonary mass of the thorax, which was proved as a LELC of the lung.
[Useful observations on various significant skin diseases and their therapy].

V. Pirila

1962-05-01

Abstract:
Antibody fragments as inhibitors of Japanese radish acid phosphatase.

R. Takata,Y. Miyamoto,K. Honjoh,T. Soeda,J. Sakamoto,T. Miyamoto,S. Hatano

DOI: https://doi.org/10.1271/BBB.62.1041

1998-06-01

Abstract:VH (heavy-chain variable region) and VL (light-chain variable region) genes were amplified by PCR from hybridomas producing MAb-11 and MAb-18 which inhibited Japanese radish acid phosphatase. Nucleotide sequencing of the V genes demonstrates that the MAbs contained similar VH and identical VL domains. Initially, the VH and VL genes were expressed in Escherichia coli as single-chain Fv (ScFv) fragments. Fragments ScFv-11 and ScFv-18, named for MAb-11 and MAb-18, respectively, inhibited the enzyme activity to the same extent as the intact MAbs. Both of the antibody fragments widely cross-reacted with other phosphatases, including some phosphomonoesterases and phosphodiesterases from different sources. ScFv-18 also inhibited acid phosphatase from a different origin, but stimulated the activity of alkaline phosphatase from calf intestine. The PCR-amplified VH and VL genes were subsequently expressed separately in Escherichia coli as fusion products with glutathione S-transferase. The fusion proteins had little effect on Japanese radish acid phosphatase. Furthermore, a large number of recombinant ScFv fragments specific to the acid phosphatase were generated by using a bacteriophage expression system and a mouse ScFv gene library. These ScFv fragments had a range of effects on the enzyme activity, including inhibition, stimulation, and none. Among them, an ScFv fragment, designated ScFv-G7, inhibited more strongly than ScFv-11 and ScFv-18.
Primary pulmonary lymphoepithelioma-like carcinoma misdiagnosed as lung squamous cell carcinoma: A case report

Chang-Jie Yin,Guang-Jie Wang,Xiao-Mei Su,Dong Li

DOI: https://doi.org/10.12998/wjcc.v11.i32.7876

2023-11-16

World Journal of Clinical Cases

Abstract:BACKGROUND Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is an uncommon subtype of squamous cell carcinoma (SCC) of the lung, closely associated with Epstein-Barr virus (EBV) infection. The pathological features of PPLELC closely resemble those of SCC, which makes it prone to misdiagnosis. Surgical intervention constitutes the primary treatment approach for PPLELC. CASE SUMMARY This report describes a 44-year-old woman who was hospitalized for 1 mo due to left chest pain. Computed tomography revealed a mass shadow in the anterior basal segment of the left lower lobe, and a subsequent needle biopsy suggested SCC. The patient underwent radical tumor resection in the lower left lobe of the lung, and postoperative pathological examination indicated lymphoepithelial carcinoma, and the test for EBV encoded small RNA was positive. Following surgery, the patient was scheduled to receive four cycles of adjuvant chemotherapy, using the paclitaxel + carboplatin regimen, but the patient refused further treatment. CONCLUSION PPLELC is an exceptionally rare subtype of lung SCC and is prone to misdiagnosis.

medicine, general & internal
The Genomic Landscape of Epstein-Barr Virus-Associated Pulmonary Lymphoepithelioma-Like Carcinoma

Shaodong Hong,Dongbing Liu,Shuzhen Luo,Wenfeng Fang,Jianhua Zhan,Sha Fu,Yaxiong Zhang,Xuan Wu,Huaqiang Zhou,Xi Chen,Gang Chen,Zhonghan Zhang,Qiufan Zheng,Xiaobo Li,Jinghao Chen,Xingmin Liu,Mengyue Lei,Chen Ye,Jian Wang,Huanming Yang,Xun Xu,Shida Zhu,Yunpeng Yang,Yuanyuan Zhao,Ningning Zhou,Hongyun Zhao,Yan Huang,Lanjun Zhang,Kui Wu,Li Zhang

DOI: https://doi.org/10.1038/s41467-019-10902-w

IF: 16.6

2019-01-01

Nature Communications

Abstract:Pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare and distinct subtype of primary lung cancer characterized by Epstein-Barr virus (EBV) infection. Herein, we reported the mutational landscape of pulmonary LELC using whole-exome sequencing, targeted deep sequencing and single-nucleotide polymorphism arrays. We identify a low degree of somatic mutation but widespread existence of copy number variations. We reveal predominant signature 2 mutations and frequent loss of type I interferon genes that are involved in the host-virus counteraction. Integrated analysis shows enrichment of genetic lesions affecting several critical pathways, including NF-κB, JAK/STAT, and cell cycle. Notably, multi-dimensional comparison unveils that pulmonary LELC resemble NPC but are clearly different from other lung cancers, natural killer/T-cell lymphoma or EBV-related gastric cancer in terms of genetic features. In all, our study illustrates a distinct genomic landscape of pulmonary LELC and provides a road map to facilitate genome-guided personalized treatment.

[A case of Tsutsugamushi disease with multiple organ involvement].

Epstein-Barr virus-associated leiomyosarcoma of the larynx in an adult patient with human immunodeficiency virus infection: Case report and review of the literature

Epstein–Barr Virus‐associated Leiomyosarcoma of the Larynx in an Adult Patient with Human Immunodeficiency Virus Infection: Case Report and Review of the Literature

Closures and dichotomies for quantified constraints

Epstein-Barr Virus-Associated Lymphoepithelioma-Like Gastric Carcinoma Located on Gastric High Body: Two Case Reports.

Pulmonary lymphoepithelioma-like carcinoma

P35.22 WITHDRAWN

Surgical Treatment of Epstein-Barr Virus–associated Lymphoepithelioma-Like Carcinoma Occurring in Both the Posterior Mediastinum and Liver

Lymphocytic hypophysitis presenting early in pregnancy

[A Rare Case of Non-small Cell Lung Carcinoma Squamous Phenotype with Epstein-Barr Virus Positivity with Prolonged Response to both Chemotherapy and Radiotherapy].

Isolation of viruses from mosquitoes collected at Lumbo, Mozambique. I. Lumbo virus, a new virus isolated from Aedes (Skusea) pembaensis Theobald.

A Clinical Analysis and Literature Review of Six Cases with Primary Pulmonary Lymphoepithelioma-Like Carcinoma

Primary lymphoepithelioma-like carcinoma of the lung: An unusual cancer and clinical outcomes of 14 patients

PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival

Clinical observation of pulmonary lymphoepithelioma-like carcinoma

Neoadjuvant Therapy Before Resection of Primary Pulmonary Lymphoepithelial Carcinoma

Lymphoepithelioma-like carcinoma of the lung: a rare case report and review of the literature

[Useful observations on various significant skin diseases and their therapy].

Antibody fragments as inhibitors of Japanese radish acid phosphatase.

Primary pulmonary lymphoepithelioma-like carcinoma misdiagnosed as lung squamous cell carcinoma: A case report

The Genomic Landscape of Epstein-Barr Virus-Associated Pulmonary Lymphoepithelioma-Like Carcinoma